Rapid Tests Market Size and Growth Forecast for Businesses 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Rapid Tests Market?

The rapid tests market has seen substantial expansion during recent years. It is forecast to increase from $31.07 billion in 2024 to $34.67 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.6%. The historical growth of this market is attributable to the increasing prevalence of infectious diseases, a rising demand for point-of-care diagnostics, enhanced awareness for early disease detection, the growing necessity for rapid and accurate test results, and improvements in healthcare expenditure and accessibility.

The rapid tests market size is anticipated to expand quickly in the coming years. This market is projected to reach $53.17 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.3%. The expansion during this period is attributable to several factors, including the increasing acceptance of home-based testing kits, a greater emphasis on personalized medicine, heightened demand for rapid testing in developing economies, and the broader application of rapid tests in unconventional environments. Key developments expected in the forecast timeframe encompass progress in microfluidic technologies, the incorporation of advanced biosensors into test kits, breakthroughs in multiplex rapid testing platforms, the integration of artificial intelligence (AI) into diagnostic processes, and improvements in portable diagnostic devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25892&type=smp

Which Drivers Are Impacting The Rapid Tests Market?

The increasing occurrence of infectious diseases is anticipated to fuel the expansion of the rapid tests market moving forward. Infectious diseases are conditions caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading directly or indirectly between individuals. The growing prevalence of these diseases is attributed to increased global travel, which facilitates the swift movement of pathogens across borders. Rapid tests are crucial in combating infectious diseases by enabling quick and accurate detection at the point of care, allowing for timely intervention and isolation. They support public health efforts by minimizing diagnostic delays, improving disease management, and restricting the spread of infections. For example, in February 2024, the UK Health Security Agency, a UK-based government body, reported that tuberculosis (a contagious bacterial infection primarily affecting the lungs) cases in England increased to 4,850 in 2023, a rise of 10.7% from 4,380 cases recorded in 2022. Thus, the escalating incidence of infectious diseases is a primary catalyst for the growth of the rapid tests market.

What Are The Key Segments In The Rapid Tests Market?

The rapid tests market covered in this report is segmented –

1) By Product: Instruments, Consumables, Other Products

2) By Contaminants: Pathogens, Allergens, Meat Speciation, Pesticides, Other Contaminants

3) By Technology: Polymerase Chain Reaction (PCR)-Based, Immunoassay-Based, Chromatography-Based, Spectroscopy-Based

4) By Application: Cardiology, Oncology, Pregnancy And Fertility, Toxicology, Glucose Monitoring, Infectious Disease, Other Applications

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End-Users

Subsegments:

1) By Instruments: Portable Analyzers, Benchtop Analyzers, Handheld Devices, Readers Or Scanners, Multiplex Analyzers

2) By Consumables: Test Strips, Test Cassettes Or Cartridges, Reagents, Sample Collection Devices, Control And Calibration Materials

3) By Other Products: Software And Data Management Systems, Accessories, Maintenance And Service Kits, Packaging Materials, Training And Support Materials

Which Market Trends Are Creating New Opportunities In The Rapid Tests Industry?

Leading companies within the rapid tests market are concentrating on developing sophisticated technological solutions, such as advanced bioluminescence technology, to facilitate faster, more sensitive, and accurate pathogen identification. Advanced bioluminescence technology utilizes light-emitting biochemical reactions, typically involving luciferase enzymes and substrates, to detect the presence of microorganisms or biological markers. For instance, in March 2025, Nelson Labs, a US-based testing services provider, introduced a rapid sterility testing method. This new testing approach significantly reduces the traditional 14-day incubation period to as little as six days through the application of advanced bioluminescence technology. The system identifies microbial adenosine triphosphate (ATP), a clear indicator of living organisms, by measuring the light produced during the bioluminescent reaction. This automates the detection of microbial contamination, enhances accuracy, and ensures regulatory compliance, thereby enabling quicker, reliable product release without compromising safety.

Who Are The Primary Competitors In The Global Rapid Tests Market?

Major companies operating in the rapid tests market are Pfizer Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers, BioMérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., PerkinElmer Inc., OraSure Technologies Inc., SEKISUI Diagnostics LLC, Trivitron Healthcare Pvt. Ltd., Ellume Limited, Access Bio Inc., ACON Laboratories Inc., CTK Biotech Inc., iHealth Labs Inc., Wondfo USA Co. Ltd., InBios International Inc., Lab Care Diagnostics India Pvt. Ltd., Immunostics Inc., Aptitude Medical Systems Inc., Nano-Ditech Corporation, Azure Biotech Inc., Beijing Hotgen Biotech Co. Ltd., CorDx Inc., Genabio Diagnostics Inc., Maxim Biomedical Inc., OSANG LLC, Watmind USA.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/rapid-tests-global-market-report

How Is Rapid Tests Market Demand Varying Across Different Regions?

North America was the largest region in the rapid tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Rapid Tests Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25892&type=smp

Browse Through More Reports Similar to the Global Rapid Tests Market 2025, By The Business Research Company

Veterinary Rapid Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-rapid-test-global-market-report

Esoteric Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/esoteric-testing-global-market-report

Female Fertility And Pregnancy Rapid Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/female-fertility-and-pregnancy-rapid-test-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795